Tocolytics and Preterm Labour: Buying Time for the Baby

What tocolytics actually do — and don't

A tocolytic relaxes the uterus. That is a means, not an end. Preterm labour is regular contractions with cervical change before 37 weeks, and the damage of prematurity is done by the immature organs of the newborn — above all the lungs. Here is the humbling fact the trials keep confirming: tocolytics reliably delay delivery for up to about 48 hours, but on their own they do not reduce neonatal death or serious complications. So why give them at all? Because those 48 hours are a window. They are exactly long enough to complete a course of antenatal corticosteroids and to move the mother to a unit with neonatal intensive care. The whole value of a tocolytic is borrowed from what you do with the time it buys.

The agents and how they relax the myometrium

Every tocolytic works by lowering the drive to contract in the myometrium. Myometrial contraction is ultimately triggered by a rise in intracellular calcium, and stimulated by oxytocin and prostaglandins. Each drug class interrupts one link in that chain. Nifedipine, a calcium-channel blocker, reduces the calcium influx that drives contraction — it is oral, widely used first-line, and its main caution is maternal hypotension (the same vasodilator effect covered in the Cardiovascular section, where nifedipine treats hypertension and angina). Atosiban is an oxytocin-receptor antagonist: it blocks oxytocin at its receptor on the myometrium, and because oxytocin signalling is largely confined to the uterus it causes very few maternal side effects — which makes it the favoured agent where cost and availability allow (the oxytocin receptor itself is taught in the Endocrine section).

The older beta-2 agonists — terbutaline and ritodrine — relax the myometrium by stimulating beta-2 adrenoceptors, but they are far from selective and stimulate the mother's heart and metabolism too. The result is troublesome maternal effects: tachycardia, palpitations, tremor, hyperglycaemia and, dangerously, pulmonary oedema. For this reason they have largely fallen out of favour as maintenance tocolytics, though terbutaline remains handy as a quick single dose to relax an over-contracting uterus — for example in uterine hyperstimulation during induction (a use cross-referenced in the Labour-induction chapter). Indometacin, a non-steroidal anti-inflammatory drug, blocks prostaglandin synthesis (the same COX inhibition taught in the Inflammation section) and is an effective tocolytic — but it carries specific fetal hazards: it can cause premature narrowing or closure of the ductus arteriosus and reduce fetal urine output leading to oligohydramnios. So it is reserved for short courses and generally only below 32 weeks. Finally, the nitric-oxide donors such as glyceryl trinitrate (GTN) relax smooth muscle via cGMP but play only a minor, secondary role.

Antenatal corticosteroids: the drug that truly matters

If you remember one thing from this chapter, remember this drug — not the tocolytic. A single course of antenatal corticosteroids — betamethasone or dexamethasone given to the mother — is arguably the single most valuable drug intervention in all of obstetrics. The steroid crosses the placenta and accelerates maturation of the fetal lungs, driving the production of surfactant, the substance that keeps the tiny air sacs from collapsing at each breath. The effect is dramatic and well proven: a course given to a woman at risk of preterm birth markedly reduces neonatal respiratory distress syndrome, intraventricular haemorrhage (bleeding in the premature brain), necrotising enterocolitis and neonatal death. This is precisely the outcome tocolytics cannot deliver on their own — and precisely why the 48-hour window exists. The steroids share the mechanism taught in the Endocrine section (glucocorticoid action on gene transcription), here turned to a single, elegant fetal purpose: ripening the lungs before birth.

Magnesium sulfate: protecting the preterm brain

The second co-therapy answers a different question: not the lungs, but the brain. Given to the mother when very preterm birth (broadly before about 30–32 weeks) is imminent, magnesium sulfate reduces the risk of cerebral palsy and gross motor dysfunction in the surviving child — it is a fetal neuroprotectant. This is a distinct indication from its role in obstetrics that most students learn first: seizure prevention and treatment in severe pre-eclampsia and eclampsia. Same drug, same infusion, two entirely different purposes — and the Pre-eclampsia chapter covers the seizure-prophylaxis use in full, including the toxicity you must watch for. Magnesium toxicity announces itself in order: loss of the deep tendon reflexes first, then respiratory depression, then cardiac arrest — and it is reversed by intravenous calcium gluconate, while monitoring reflexes, respiratory rate and urine output (magnesium is renally cleared, so oliguria lets it accumulate).

When NOT to delay: contraindications to tocolysis

Delaying delivery is only right when the womb is still the safest place for the baby. Sometimes it isn't — and then prolonging the pregnancy causes harm. Tocolysis is contraindicated when there is intrauterine infection (chorioamnionitis), because keeping an infected baby inside worsens sepsis in both mother and fetus. It is contraindicated when the fetus is already compromised — a non-reassuring fetal heart pattern or severe growth restriction — because those babies are safer delivered than left in a failing environment. And it is contraindicated with significant maternal haemorrhage, such as a major antepartum bleed or placental abruption, where relaxing the uterus can worsen bleeding and where delivery is the treatment. The principle is simple: do not prolong a pregnancy that should end. A tocolytic is a tool for buying safe time, not for overriding the reasons a baby needs to be born.